Literature DB >> 3595289

[Course and anastomoses of the large hepatic veins to main structures on the liver surface].

M Appel, H Loeweneck.   

Abstract

The upper liver veins of fifty adult people were dissected from their orifices up to their second ramifications. The courses of the hepatic veins to the main portal fissure and umbilical fissure were determined. Three large upper hepatic veins can be expected in 74%, an accessory one occurs in 26%. The three or four upper hepatic veins join V. cava inferior by two (66%) or three (34%) common terminal branches (length 0.9 cm). Mean diameters of right hepatic vein 1.5 cm, middle hepatic and left hepatic veins 1 cm, accessory upper hepatic vein 0.6 cm. The course of the middle hepatic vein to "cava-gallbladder-line" was determined. The most common vein of the umbilical fissure joins the left, occasionally the middle hepatic vein. The intrahepatic distribution of the liver veins was projected to the surface of the liver considering the typical resection lines. We recommend the following anatomical way of proceeding: right extended and left lateral lobectomy remain right to lig. falciforme hepatis; right lobectomy 1 cm right, left lobectomy 1 cm left to "cava-gallbladder-line".

Entities:  

Mesh:

Year:  1987        PMID: 3595289

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  3 in total

1.  Magnetic resonance imaging of the liver by oblique sections.

Authors:  J Champetier; J F Le Bas; H Haouari; P Chaffanjon
Journal:  Surg Radiol Anat       Date:  1992       Impact factor: 1.246

2.  The portal bifurcation and the termination of the hepatic veins: an anatomical investigation into the projection of the ultrasonographically important hepatic vessels onto the anterior body wall.

Authors:  T Sauer; H Loeweneck
Journal:  Surg Radiol Anat       Date:  1991       Impact factor: 1.246

3.  Anatomic basis of vascular exclusion of the liver.

Authors:  J M Chevallier
Journal:  Surg Radiol Anat       Date:  1988       Impact factor: 1.246

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.